Brand Name: Sorini
Generic Name: Nimesulide
Indications: Painful or non painful inflammatory condition affecting soft tissue or
musculoskeletal system, dysmenorrhea, post op pain, inflammation of dental
tissue, RA, acute inflammation on upper airway.
Drug Classification: Anti-rheumatic, anti-inflammatory analgesics.
Mechanism of action: Nimesulide is rapidly (peak plasma concentration in 1-4 hours)
and extensively absorbed after oral administration. The drug can be given as
rectal suppository but it is about 70% as bioavailable rectally as orally
administered. The compound is extensively bound to plasma proteins. The
average half-life of administration is about 3 hours. Nimesulide is metabolized
primarily to alphe, 4-hydroxy derivative and metabolites are primarily excreted
from the kidney.
Dosage: Adult: 50-100 mg bid, if necessary up to 200 mg bid. Mild cases and long
tyherapy 75-100mg daily.
Special Precaution: Elderly, weak patients with bleeding disease or upper gastric
disease, on anticoagulant or antiplatelet drug.
Pregnancy Risk Category:
Adverse reaction: Occasionally mild transient heartburn, nausea, stomachache. Rarely
purpura, vertigo, drowsiness, erythema, exsudativum multiforme, Stevens-
Jonhson syndrome, peptic ulcer, GI bleeding, perforation and bloody excrement.
Contraindication: Peptic ulcer, gastrostaxis, pregnancy, lactation and children.
Hypersensitivity to NSAIDs
Form: Tab 100 mg
Nursing Responsibilities:
Monitor patient for adverse reactions.
Screen for any of the following known allergies to salicylates, NSAIDs, or
tartrazine, renal disease, bleeding disorder, chicken pox or influenza.